FDA — authorised 22 April 1970
- Marketing authorisation holder: AMPHASTAR PHARMS INC
- Status: approved
🇺🇸 Cortrosyn in United States
FDA authorised Cortrosyn on 22 April 1970
Marketing authorisation
Cortrosyn in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Cortrosyn approved in United States?
Yes. FDA authorised it on 22 April 1970.
Who is the marketing authorisation holder for Cortrosyn in United States?
AMPHASTAR PHARMS INC holds the US marketing authorisation.